Bone morphogenetic proteins in vascular homeostasis and disease
MJ Goumans, A Zwijsen… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
It is well established that control of vascular morphogenesis and homeostasis is regulated
by vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), Delta-like 4 …
by vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), Delta-like 4 …
Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy
H Roedig, MV Nastase, M Wygrecka… - The FEBS …, 2019 - Wiley Online Library
It is well established that biglycan, a small leucine‐rich proteoglycan, acts as an extracellular
matrix‐derived danger signal in its soluble form. By binding to innate immunity Toll‐like …
matrix‐derived danger signal in its soluble form. By binding to innate immunity Toll‐like …
Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3
E The, DM de Graaf, Y Zhai, Q Yao… - Proceedings of the …, 2022 - National Acad Sciences
Calcific aortic valve disease (CAVD) is common in people over the age of 65. Progressive
valvular calcification is a characteristic of CAVD and due to chronic inflammation in aortic …
valvular calcification is a characteristic of CAVD and due to chronic inflammation in aortic …
[HTML][HTML] Silk sericin application increases bone morphogenic protein-2/4 expression via a toll-like receptor-mediated pathway
Abstract Bone morphogenic protein-2/4 (BMP-2/4) is an osteoinductive protein that
accelerates osteogenesis when administered to bony defects. Sericin is produced by …
accelerates osteogenesis when administered to bony defects. Sericin is produced by …
Proteoglycans in Toll-like receptor responses and innate immunity
S Garantziotis, RC Savani - American Journal of Physiology …, 2022 - journals.physiology.org
The extracellular matrix (ECM) is an active and dynamic feature of tissues that not only
provides gross structure but also plays key roles in cellular responses. The ever-changing …
provides gross structure but also plays key roles in cellular responses. The ever-changing …
Single-cell RNA sequencing reveals cell type-and artery type-specific vascular remodelling in male spontaneously hypertensive rats
Aims Hypertension is a major risk factor for cardiovascular diseases. However, vascular
remodelling, a hallmark of hypertension, has not been systematically characterized yet. We …
remodelling, a hallmark of hypertension, has not been systematically characterized yet. We …
Toll-like receptors, inflammation, and calcific aortic valve disease
C García-Rodríguez, I Parra-Izquierdo… - Frontiers in …, 2018 - frontiersin.org
Inflammation, the primary response of innate immunity, is essential to initiate the calcification
process underlying calcific aortic valve disease (CAVD), the most prevalent valvulopathy in …
process underlying calcific aortic valve disease (CAVD), the most prevalent valvulopathy in …
Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance
S Appunni, M Rubens, V Ramamoorthy… - Molecular and Cellular …, 2021 - Springer
Extracellular matrix (ECM) plays an important role in the structural organization of tissue and
delivery of external cues to the cell. Biglycan, a class I small leucine-rich proteoglycans …
delivery of external cues to the cell. Biglycan, a class I small leucine-rich proteoglycans …
Long noncoding TSI attenuates aortic valve calcification by suppressing TGF-β1-induced osteoblastic differentiation of valve interstitial cells
Z Liu, Y Wang, F Liu, D Zhu, Y Chen, WY Yim, K Hu… - Metabolism, 2023 - Elsevier
Introduction Calcific aortic valve disease (CAVD) is an active and cellular-driven fibrocalcific
process characterised by differentiation of valve interstitial cells (VICs) towards an …
process characterised by differentiation of valve interstitial cells (VICs) towards an …
Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
SP Nejad, MC Blaser, JP Santerre… - Advanced drug delivery …, 2016 - Elsevier
Surgical replacement of dysfunctional valves is the primary option for the treatment of
valvular disease and congenital defects. Existing mechanical and bioprosthetic replacement …
valvular disease and congenital defects. Existing mechanical and bioprosthetic replacement …